Lifeward director granted 7,657 RSUs

Lifeward Ltd. director Nadav Kidron received an equity award valued in shares rather than cash.

Rhea-AI Filing Summary

Lifeward Ltd. director Nadav Kidron received an equity award valued in shares rather than cash. On the grant date of March 25, 2026, he was granted 7,657 restricted stock units (RSUs) under the company’s 2025 Incentive Compensation Plan at no cash purchase price.

The RSUs convert into ordinary shares in four equal quarterly installments, beginning three months after the grant date. Following this award, Kidron’s reported direct holdings total 7,657 ordinary shares, reflecting the shares issuable upon vesting of this initial RSU grant.

Insider Trade Summary

Grant/Award: 7,657 shares

Grant/Award 1 txn

Insider KIDRON NADAV

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares, no par value per share	7,657	$0.00	$0.00

Holdings After Transaction: Ordinary Shares, no par value per share — 7,657 shares (Direct)

Footnotes (1)

1. F1. Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Lifeward (LFWD) report for Nadav Kidron?

Lifeward reported that director Nadav Kidron received an equity grant, not an open-market purchase. He was awarded 7,657 restricted stock units on March 25, 2026 under the 2025 Incentive Compensation Plan, which will convert into ordinary shares as they vest over time.

Is Nadav Kidron’s Lifeward (LFWD) Form 4 transaction a stock purchase or compensation grant?

The Form 4 shows a compensation grant, not a stock purchase. Kidron received 7,657 restricted stock units at a zero dollar price per share, reflecting equity awarded under Lifeward’s 2025 Incentive Compensation Plan rather than shares bought in the open market for cash.

How many Lifeward (LFWD) shares are tied to Nadav Kidron’s new RSU award?

The award covers 7,657 ordinary shares of Lifeward, issuable upon RSU vesting. These restricted stock units represent potential future shares, which will be delivered in installments as they vest according to the quarterly vesting schedule disclosed for this specific compensation grant.

What is the vesting schedule for Nadav Kidron’s Lifeward (LFWD) RSUs?

The RSUs vest in four equal quarterly installments starting three months after the March 25, 2026 grant date. Each quarter, one-quarter of the 7,657 units converts into ordinary shares, assuming continued satisfaction of the vesting terms specified in Lifeward’s incentive plan.

What are Nadav Kidron’s reported Lifeward (LFWD) holdings after this Form 4 transaction?

After the reported transaction, Kidron’s direct position is 7,657 ordinary shares linked to the RSU grant. This figure reflects the total number of shares underlying the awarded restricted stock units, which will become actual shares only as each quarterly tranche vests over time.

Under which plan were Nadav Kidron’s Lifeward (LFWD) RSUs granted?

The restricted stock units were granted under Lifeward’s 2025 Incentive Compensation Plan. This plan is used to deliver equity-based compensation, awarding 7,657 RSUs to director Nadav Kidron on March 25, 2026, with those units settling in ordinary shares upon future vesting dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 04:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIDRON NADAV

(Last) (First) (Middle)

C/O LIFEWARD LTD.

2 CABOT RD.

(Street)

HUDSON MASSACHUSETTS 01749

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares, no par value per share	03/25/2026		A		7,657(1)	A	$0.00	7,657	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

	/s/ Almog Adar, as Attorney-in-Fact for Nadav Kidron.	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)